CYP17A1 and coronary artery disorder: Of these, BCAS3, COL4A1, COL4A2, SMAD3 and CYP17A1 had evidence of estrogen modulating some aspect of CAD development, and the rest had estrogen modulation evidence in other tissues (e.g., breast tissue, uterine endothelium).